Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Elixxer Ltd. (V:ELXR)

Business Focus: Pharmaceuticals

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for ELXR within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Mar 26, 2020 02:00 ET
LITTLE GREEN PHARMA UPDATE - COMMISSIONING OF CULTIVATION FACILITY EXPANSION COMPLETE
ELIXXER, LTD. (TSX.V: ELXR.  OTCQB: ELIXF GR: 2LQA) (“ELXR” or the “Company”)”) is pleased to announce that Little Green Pharma has completed the commissioning of its expanded cultivation facility in Western Australia. The facility expansion was...
Read full article
Mar 17, 2020 18:30 ET
ELIXXER LTD. COMPLETES CONVERTIBLE LOAN TRANSACTION OF US$1,183,000
Elixxer Ltd. (the “Corporation” or “Elixxer”) (TSX-V: ELXR and OTC-QB: ELIXF) is pleased to announce that, following receipt of conditional approval from the TSX Venture Exchange, it has now closed its previously announced convertible loan...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
1.27
--
--
Price to Sales - TTM
16.77
3.05
7.06
Price to Book - most recent quarter
0.88
1.42
1.56
Price to Cash Flow per share - TTM
--
5.91
6.89
Price to Free Cash Flow per share - TTM
--
4.41
13.66
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Mar 15, 202070,02453,700
Feb 29, 202016,3249,080
Feb 15, 20207,244-636,097
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Elixxer Ltd, formerly LGC Capital Ltd, is a Canada-based cannabis investment company. The Company is focused on the legal global cannabis market. It is focused on cultivation, processing and distribution in Australia, Jamaica, Switzerland, Italy and Canada serving domestic and export markets. It sells cannabis products across Switzerland and Italy under the ONE Premium Cannabis and EasyJoint brands, as well as medical cannabis oils in Australia under the Little Green Pharma brand. Its products are available in a range of formats, including dry cannabis flower, tinctures, oils, seeds, and beverages.

See business summary

Twitter

Search (past week) for $ELXR.CA ELXR.V

  • No tweets found